M. Gurram et al., AUGMENTED INTERLEUKIN-6 SECRETION IN COLLAGEN-STIMULATED PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM PATIENTS WITH SYSTEMIC-SCLEROSIS, Annals of allergy, 73(6), 1994, pp. 493-496
Background: Systemic sclerosis is an autoimmune disease that is associ
ated with excessive fibroblast proliferation and collagen deposition i
n various tissues, Interleukin-6 (IL-6) is produced by fibroblasts, ac
tivated T and B lymphocytes, which maybe involved in the pathogenesis
of systemic sclerosis. Objective: This study was performed in order to
determine whether IL-6 could be detected specifically in collagen-sti
mulated peripheral blood mononuclear cells from patients with systemic
sclerosis. Methods: We clinically evaluated seven patients with syste
mic sclerosis for disease duration and organ involvement and analyzed
in vitro the ability of their peripheral blood mononuclear cells and t
hose of disease-free controls, in the presence of concanavalin A, huma
n type I collagen, and the mast eel mediator, heparin to secrete IL-6
spontaneously by a sensitive ELISA. Results: Interleukin-6 production
by nonspecific stimulation with concanavalin A did not differ between
patients with systemic sclerosis and controls; however, collagen stimu
lation significantly increased IL-6 production in patients with system
ic sclerosis; mean 1728 pg/mL versus a mean of 386 pg/mL in controls P
= <.05). Collagen-stimulated IL-6 levels >2000 pg/mL were obtained in
86% of patients with systemic sclerosis compared with none in the con
trols. In patients with systemic sclerosis with a shorter disease dura
tion, greater spontaneous as well as collagen- and heparin-stimulated
IL-6 production was observed, whereas decreased IL-6 levels were noted
with longer disease duration (>21 years). Conclusions: The results of
this study suggest that peripheral blood mononuclear cells from patie
nts with systemic sclerosis are specifically sensitized to human type
I collagen to produce increased levels of IL-6, which may play a role
in the pathogenesis in this fibrotic disorder.